相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme
Chandni Hindocha et al.
ADDICTION BIOLOGY (2020)
Heavy cannabis use, dependence and the brain: a clinical perspective
Emese Kroon et al.
ADDICTION (2020)
Psychometric properties of the perceived stigma towards substance users scale: factor structure, internal consistency, and associations with help-seeking variables
Antover P. Tuliao et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2020)
'Standard THC units': a proposal to standardize dose across all cannabis products and methods of administration
Tom P. Freeman et al.
ADDICTION (2020)
Substance use: Interplay between polygenic risk and neighborhood environment
Joelle A. Pasman et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Trends in Reported Marijuana Vaping Among US Adolescents, 2017-2019
Richard A. Miech et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Vaporized Cannabis Extracts Have Reinforcing Properties and Support Conditioned Drug-Seeking Behavior in Rats
Timothy G. Freels et al.
JOURNAL OF NEUROSCIENCE (2020)
Neurocognitive consequences of chronic cannabis use: a systematic review and meta-analysis
Pedro Rafael Figueiredo et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda
Mallory J. E. Loflin et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Adolescent cannabis use, cognition, brain health and educational outcomes: A review of the evidence
Valentina Lorenzetti et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
The importance of psychology for shaping legal cannabis regulation.
Jacob T. Borodovsky et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2020)
Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990-2019: Systematic review and meta-analysis
Glenn E. Hunt et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Adolescent cannabis exposure increases heroin reinforcement in rats genetically vulnerable to addiction
Daniele Lecca et al.
NEUROPHARMACOLOGY (2020)
Classics in Neuroimaging: Imaging the Endocannabinoid Pathway with PET
Cassis Varlow et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Screening for Unhealthy Drug Use US Preventive Services Task Force Recommendation Statement
Alex H. Krist et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Acute and residual mood and cognitive performance of young adults following smoked cannabis
Justin Matheson et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets
Seyed Alireza Salami et al.
MOLECULES (2020)
Cannabis Legalization and Acute Harm From High Potency Cannabis Products: A Narrative Review and Recommendations for Public Health
Justin Matheson et al.
FRONTIERS IN PSYCHIATRY (2020)
Cannabis Exposure During Critical Windows of Development: Epigenetic and Molecular Pathways Implicated in Neuropsychiatric Disease
Anna Smith et al.
CURRENT ENVIRONMENTAL HEALTH REPORTS (2020)
The effects of fifteen evidence-supported therapies for adult depression: A meta-analytic review
Pim Cuijpers et al.
PSYCHOTHERAPY RESEARCH (2020)
Cannabis Use in Adolescence: A Review of Neuroimaging Findings
Yann Chye et al.
JOURNAL OF DUAL DIAGNOSIS (2020)
Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids A Systematic Review and Meta-analysis
Anees Bahji et al.
JAMA NETWORK OPEN (2020)
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
Tom P. Freeman et al.
LANCET PSYCHIATRY (2020)
Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies
Matthew E. Sloan et al.
ACTA PHARMACOLOGICA SINICA (2019)
How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review
Eva Hoch et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)
Does regular cannabis use affect neuroanatomy? An updated systematic review and meta-analysis of structural neuroimaging studies
Valentina Lorenzetti et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)
Cannabis use and suicide attempts among 86,254 adolescents aged 12-15 years from 21 low- and middle-income countries
Andre F. Carvalho et al.
EUROPEAN PSYCHIATRY (2019)
Relationships between marijuana use, severity of marijuana-related problems, and health-related quality of life
Jung-Yu Liao et al.
PSYCHIATRY RESEARCH (2019)
Blunts versus joints: Cannabis use characteristics and consequences among it treatment-seeking adults
LaTrice Montgomery et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
Effects of Adolescent Δ9-Tetrahydrocannabinol Exposure on the Behavioral Effects of Cocaine in Adult Sprague-Dawley Rats
Amy L. Friedman et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2019)
The Need for Federal Regulation of Marijuana Marketing
John W. Ayers et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Short- and long-term effects of digital prevention and treatment interventions for cannabis use reduction: A systematic review and meta-analysis
Nikolaos Boumparis et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
The prevalence and clinical correlates of cannabis use and cannabis use disorder among patients with bipolar disorder: A systematic review with meta-analysis and meta-regression
Jairo Vinicius Pinto et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Cannabinoid hyperemesis syndrome
Yaniv Chocron et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
The Insula: A Brain Stimulation Target for the Treatment of Addiction
Christine Ibrahim et al.
FRONTIERS IN PHARMACOLOGY (2019)
Public health implications of legalising the production and sale of cannabis for medicinal and recreational use
Wayne Hall et al.
LANCET (2019)
Psychosocial moderation of polygenic risk for cannabis involvement: the role of trauma exposure and frequency of religious service attendance
Jacquelyn L. Meyers et al.
TRANSLATIONAL PSYCHIATRY (2019)
Several clock genes polymorphisms are meaningful risk factors in the development and severity of cannabis addiction
Raphael Saffroy et al.
CHRONOBIOLOGY INTERNATIONAL (2019)
Testing the biosocial cognitive model of substance use in cannabis users referred to treatment
Zoe E. Papinczak et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder
Dustin C. Lee et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in US adults
Ofir Livne et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use
Alan J. Budney et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)
Recent trends in cyclic vomiting syndrome-associated hospitalisations with liberalisation of cannabis use in the state of Colorado
Sanjay Bhandari et al.
INTERNAL MEDICINE JOURNAL (2019)
The neuropsychopharmacology of cannabis: A review of human imaging studies
Michael A. P. Bloomfield et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders
Geoffrey M. Reed et al.
WORLD PSYCHIATRY (2019)
Contingency Management Using Incentives to Improve Outcomes for Adolescent Substance Use Disorders
Catherine Stanger et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2019)
Prevalence of Cannabis Use in Youths After Legalization in Washington State
Julia A. Dilley et al.
JAMA PEDIATRICS (2019)
How and why have attitudes about cannabis legalization changed so much?
Jacob Felson et al.
SOCIAL SCIENCE RESEARCH (2019)
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
Marta Di Forti et al.
LANCET PSYCHIATRY (2019)
Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial
Deepak Cyril D'Souza et al.
LANCET PSYCHIATRY (2019)
Chronic Δ9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability
William S. John et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Genome-wide association study identifies a novel locus for cannabis dependence
A. Agrawal et al.
MOLECULAR PSYCHIATRY (2018)
CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity
Arnau Busquets-Garcia et al.
NEUROPSYCHOPHARMACOLOGY (2018)
The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal
Christina A. Brezing et al.
NEUROPSYCHOPHARMACOLOGY (2018)
US Epidemiology of Cannabis Use and Associated Problems
Deborah S. Hasin
NEUROPSYCHOPHARMACOLOGY (2018)
Global statistics on alcohol, tobacco and illicit drug use: 2017 status report
Amy Peacock et al.
ADDICTION (2018)
It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis
Wayne Hall et al.
ADDICTION (2018)
Whole-of-community interventions to reduce population-level harms arising from alcohol and other drug use: a systematic review and meta-analysis
Emily Stockings et al.
ADDICTION (2018)
A biosocial cognitive model of cannabis use in emerging adulthood
Zoe E. Papinczak et al.
ADDICTIVE BEHAVIORS (2018)
DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and Related Conditions-III: Gender-specific profiles
Bradley T. Kerridge et al.
ADDICTIVE BEHAVIORS (2018)
The Canadian Cannabis Act legalizes and regulates recreational cannabis use in 2018
Chelsea Cox
HEALTH POLICY (2018)
Predictors of Topiramate Tolerability in Heavy Cannabis-Using Adolescents and Young Adults: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial
Joshua C. Gray et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2018)
Cannabis Addiction and the Brain: a Review
Amna Zehra et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2018)
Neuroimaging meta-analysis of cannabis use studies reveals convergent functional alterations in brain regions supporting cognitive control and reward processing
Julio A. Yanes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
INSTABILITY AND ITS GOVERNMENT REGULATION
Annie Levesque et al.
MEDICAL CLINICS OF NORTH AMERICA (2018)
High times for cannabis: Epigenetic imprint and its legacy on brain and behavior
Henrietta Szutorisz et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands
Tom P. Freeman et al.
PSYCHOLOGICAL MEDICINE (2018)
Overlap of heritable influences between cannabis use disorder, frequency of use and opportunity to use cannabis: trivariate twin modelling and implications for genetic design
Lindsey A. Hines et al.
PSYCHOLOGICAL MEDICINE (2018)
Open-label pilot study of injectable naltrexone for cannabis dependence
Daniel P. Notzon et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2018)
The importance of considering polysubstance use: lessons from cocaine research
Yiyang Liu et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: Systematic review and meta-analysis
Glenn E. Hunt et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia
Joelle A. Pasman et al.
NATURE NEUROSCIENCE (2018)
Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: A systematic review
Lorna Wilson et al.
SCHIZOPHRENIA RESEARCH (2018)
Epigenetic Effects of Drugs of Abuse
Thomas Heinbockel et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2018)
The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Louisa Degenhardt et al.
LANCET PSYCHIATRY (2018)
Highway to hell or magic smoke? The dose-dependence of Δ9-THC in place conditioning paradigms
Rimas A. Kubilius et al.
LEARNING & MEMORY (2018)
Feasibility and Preliminary Effectiveness of Varenicline for Treating Co-Occurring Cannabis and Tobacco Use
Tangeria R. Adams et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2018)
Whole genome sequence study of cannabis dependence in two independent cohorts
Ian R. Gizer et al.
ADDICTION BIOLOGY (2018)
Review Article: What Do We Know About the Pharmacotheraputic Management of Insomnia in Cannabis Withdrawal: A Systematic Review
Naista Zhand et al.
AMERICAN JOURNAL ON ADDICTIONS (2018)
Abstinence and reduced frequency of use are associated with improvements in quality of life among treatment-seekers with cannabis use disorder
Christina A. Brezing et al.
AMERICAN JOURNAL ON ADDICTIONS (2018)
Evidence Base on Outpatient Behavioral Treatments for Adolescent Substance Use, 2014-2017: Outcomes, Treatment Delivery, and Promising Horizons
Aaron Hogue et al.
JOURNAL OF CLINICAL CHILD AND ADOLESCENT PSYCHOLOGY (2018)
Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo-controlled pilot study
Robert Miranda et al.
ADDICTION BIOLOGY (2017)
Deficits in striatal dopamine release in cannabis dependence
E. van de Giessen et al.
MOLECULAR PSYCHIATRY (2017)
Internet-Delivered Health Interventions That Work: Systematic Review of Meta Analyses and Evaluation of Website Availability
Mary A. M. Rogers et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2017)
The potential impact of cannabis legalization on the development of cannabis use disorders
Alan J. Budney et al.
PREVENTIVE MEDICINE (2017)
Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study
Kevin P. Hill et al.
AMERICAN JOURNAL ON ADDICTIONS (2017)
Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state
Rosanna Smart et al.
ADDICTION (2017)
Mapping medical marijuana: state laws regulating patients, product safety, supply chains and dispensaries, 2017
Sarah B. Klieger et al.
ADDICTION (2017)
Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life
Yih-Ing Hser et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2017)
User characteristics and effect profile of Butane Hash Oil: An extremely high-potency cannabis concentrate
Gary C. K. Chan et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Cannabis, psychosis and schizophrenia: unravelling a complex interaction
Ian Hamilton
ADDICTION (2017)
Treatment seeking in cannabis dependence: The role of social cognition
Zoe E. Papinczak et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults
Kevin M. Gray et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations
Benedikt Fischer et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2017)
Brief Interventions for Cannabis Use Disorders: A Review
Arpit Parmar et al.
ADDICTIVE DISORDERS & THEIR TREATMENT (2017)
Building smart cannabis policy from the science up
Susan R. B. Weiss et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2017)
Recognizing and regulating cannabis as a temptation good
Jonathan P. Caulkins
INTERNATIONAL JOURNAL OF DRUG POLICY (2017)
Quality of life and recreational cannabis use
Matthew Goldenberg et al.
AMERICAN JOURNAL ON ADDICTIONS (2017)
Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review
Cecilia J. Sorensen et al.
JOURNAL OF MEDICAL TOXICOLOGY (2017)
Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study
Nanna Gilliam Toftdahl et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2016)
The effects of cannabis intoxication on motor vehicle collision revisited and revised
Ole Rogeberg et al.
ADDICTION (2016)
Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III
Deborah S. Hasin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C] CURB
Isabelle Boileau et al.
BIOLOGICAL PSYCHIATRY (2016)
Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review
Samantha J. Broyd et al.
BIOLOGICAL PSYCHIATRY (2016)
Cannabis Use in Adolescence and Young Adulthood: A Review of Findings from the Victorian Adolescent Health Cohort Study
Carolyn Coffey et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2016)
A contingency management method for 30-days abstinence in non-treatment seeking young adult cannabis users
Randi Melissa Schuster et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial
Frances R. Levin et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings
Jose M. Trigo et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
The association between cannabis use and anxiety disorders: Results from a population-based representative sample
Daniel Feingold et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability
Aliou B. Gueye et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Probability and Correlates of Dependence Among Regular Users of Alcohol, Nicotine, Cannabis, and Cocaine: Concurrent and Prospective Analyses of the National Epidemiologic Survey on Alcohol and Related Conditions
Jesse R. Cougle et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
The effects of Δ9-tetrahydrocannabinol on the dopamine system
Michael A. P. Bloomfield et al.
NATURE (2016)
Keep off the grass? Cannabis, cognition and addiction
H. Valerie Curran et al.
NATURE REVIEWS NEUROSCIENCE (2016)
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys
Charles W. Schindler et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Medical use of cannabis products Lessons to be learned from Israel and Canada
J. Ablin et al.
SCHMERZ (2016)
Cannabis and Psychosis: a Critical Overview of the Relationship
Charles Ksir et al.
CURRENT PSYCHIATRY REPORTS (2016)
Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks
Richard Sherva et al.
JAMA PSYCHIATRY (2016)
Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32330 subjects from the International Cannabis Consortium
S. Stringer et al.
TRANSLATIONAL PSYCHIATRY (2016)
Prevention, early intervention, harm reduction, and treatment of substance use in young people
Emily Stockings et al.
LANCET PSYCHIATRY (2016)
Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment: A Prospective Study
Jordan P. Davis et al.
JOURNAL OF DRUG ISSUES (2016)
Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys
Wilson M. Compton et al.
LANCET PSYCHIATRY (2016)
Technology-based Interventions for Preventing and Treating Substance Use Among Youth
Lisa A. Marsch et al.
CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA (2016)
Cannabis Use Disorder in Adolescence
Annabelle K. Simpson et al.
CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA (2016)
Cannabinoids for Medical Use A Systematic Review and Meta-analysis
Penny F. Whiting et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Alcohol burden in low-income and middle-income countries
Jason P. Connor et al.
LANCET (2015)
Endocannabinoid signalling in reward and addiction
Loren H. Parsons et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers
Margaret Haney et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Further human evidence for striatal dopamine release induced by administration of a†9-tetrahydrocannabinol (THC): selectivity to limbic striatum
Matthijs G. Bossong et al.
PSYCHOPHARMACOLOGY (2015)
Independent Evaluation of Middle School-Based Drug Prevention Curricula A Systematic Review
Anna B. Flynn et al.
JAMA PEDIATRICS (2015)
Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013
Deborah S. Hasin et al.
JAMA PSYCHIATRY (2015)
Behavioral Therapies for Treatment-Seeking Cannabis Users: A Meta-Analysis of Randomized Controlled Trials
Michelle L. Davis et al.
EVALUATION & THE HEALTH PROFESSIONS (2015)
Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments
H. Lopez-Pelayo et al.
PSYCHOLOGICAL MEDICINE (2015)
Impact of age at onset of cannabis use on cannabis dependence and driving under the influence in the United States
Yann Le Strat et al.
ACCIDENT ANALYSIS AND PREVENTION (2015)
The relationship between cannabis outcome expectancies and cannabis refusal self-efficacy in a treatment population
Jason P. Connor et al.
ADDICTION (2014)
Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms
Michael A. P. Bloomfield et al.
BIOLOGICAL PSYCHIATRY (2014)
The adverse health effects of chronic cannabis use
Wayne Hall et al.
DRUG TESTING AND ANALYSIS (2014)
Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity
Nora D. Volkow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal A Randomized Clinical Trial
David J. Allsop et al.
JAMA PSYCHIATRY (2014)
Factors associated with the timing and onset of cannabis use and cannabis use disorder: Results from the 2007 Australian National Survey of Mental Health and Well-Being
Peter Butterworth et al.
DRUG AND ALCOHOL REVIEW (2014)
DSM-5 Criteria for Substance Use Disorders: Recommendations and Rationale
Deborah S. Hasin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms
Celia J. A. Morgan et al.
BRITISH JOURNAL OF PSYCHIATRY (2013)
Predicting the transition from frequent cannabis use to cannabis dependence: A three-year prospective study
Peggy van der Pol et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Facilitators and barriers in treatment seeking for cannabis dependence
Peggy van der Pol et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Striatal D2/D3 receptor availability is inversely correlated with cannabis consumption in chronic marijuana users
Daniel S. Albrecht et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Quality of Life Following Remission of Mental Disorders: Findings From the National Epidemiologic Survey on Alcohol and Related Conditions
Jose M. Rubio et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Impulsivity, Variation in the Cannabinoid Receptor (CNR1) and Fatty Acid Amide Hydrolase (FAAH) Genes, and Marijuana-Related Problems
L. Cinnamon Bidwell et al.
JOURNAL OF STUDIES ON ALCOHOL AND DRUGS (2013)
Nabilone Decreases Marijuana Withdrawal and a Laboratory Measure of Marijuana Relapse
Margaret Haney et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Primary Prevention of Cannabis Use: A Systematic Review of Randomized Controlled Trials
Melissa M. Norberg et al.
PLOS ONE (2013)
Effect of oxytocin on craving and stress response in marijuana-dependent individuals: a pilot study
Aimee L. McRae-Clark et al.
PSYCHOPHARMACOLOGY (2013)
The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research
Jennifer M. Bossert et al.
PSYCHOPHARMACOLOGY (2013)
Polysubstance Use in Cannabis Users Referred for Treatment: Drug Use Profiles, Psychiatric Comorbidity and Cannabis-Related Beliefs
Jason P. Connor et al.
Frontiers in Psychiatry (2013)
The comparative effectiveness of outpatient treatment for adolescent substance abuse: A meta-analysis
Emily E. Tanner-Smith et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2013)
Clinical correlates of co-occurring cannabis and tobacco use: a systematic review
Erica N. Peters et al.
ADDICTION (2012)
Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study
Claire Leroy et al.
ADDICTION BIOLOGY (2012)
Validity of Timeline Follow-Back for self-reported use of cannabis and other illicit substances - Systematic review and meta-analysis
Carsten Rygaard Hjorthoj et al.
ADDICTIVE BEHAVIORS (2012)
A Double-Blind Randomized Controlled Trial of N-Acetylcysteine in Cannabis-Dependent Adolescents
Kevin M. Gray et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Prevalence, correlates and comorbidity of DSM-IV Cannabis Use and Cannabis Use Disorders in Australia
Maree Teesson et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2012)
Dopamine Release in Chronic Cannabis Users: A [11C]Raclopride Positron Emission Tomography Study
Nina B. L. Urban et al.
BIOLOGICAL PSYCHIATRY (2012)
The Effectiveness of Psychosocial Modalities in the Treatment of Alcohol Problems in Adults: A Review of the Evidence
Garth W. Martin et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2012)
Development and validation of the Cannabis Refusal Self-Efficacy Questionnaire (CRSEQ) in adult cannabis users in treatment
Ross McD. Young et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
Gender differences in health-related quality of life among cannabis users: Results from the national epidemiologic survey on alcohol and related conditions
Shaul Lev-Ran et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans
Mohini Ranganathan et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
History of cannabis use is not associated with alterations in striatal dopamine D-2/D-3 receptor availability
Paul R. A. Stokes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers
J. Hirvonen et al.
MOLECULAR PSYCHIATRY (2012)
Cannabinoid Hyperemesis: A Case Series of 98 Patients
Douglas A. Simonetta et al.
MAYO CLINIC PROCEEDINGS (2012)
A Proof-of-Concept Randomized Controlled Study of Gabapentin: Effects on Cannabis Use, Withdrawal and Executive Function Deficits in Cannabis-Dependent Adults
Barbara J. Mason et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Screening of cannabis-related problems among youth: the CPQ-A-S and CAST questionnaires
Sergio Fernandez-Artamendi et al.
SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY (2012)
State of the Art Treatments for Cannabis Dependence
Itai Danovitch et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2012)
A 'standard joint'? The role of quantity in predicting cannabis-related problems
C. Zeisser et al.
ADDICTION RESEARCH & THEORY (2012)
CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis
Amine Benyamina et al.
ADDICTION BIOLOGY (2011)
A genome-wide association study of DSM-IV cannabis dependence
Arpana Agrawal et al.
ADDICTION BIOLOGY (2011)
The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress
David J. Allsop et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
Validation of the Cannabis Expectancy Questionnaire (CEQ) in adult cannabis users in treatment
Jason P. Connor et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
Dronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trial
Frances R. Levin et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
Instruments to Detect Alcohol and Other Drug Misuse in the Emergency Department: A Systematic Review
Amanda S. Newton et al.
PEDIATRICS (2011)
Assessing problematic cannabis use
Jennifer Thake et al.
ADDICTION RESEARCH & THEORY (2011)
Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies
Karin J. H. Verweij et al.
ADDICTION (2010)
Validation of a measure to assess alcohol- and marijuana-related risks and consequences among incarcerated adolescents
L. A. R. Stein et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
Neurocircuitry of Addiction
George F. Koob et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Opioid antagonism enhances marijuana's effects in heavy marijuana smokers
Ziva D. Cooper et al.
PSYCHOPHARMACOLOGY (2010)
A Meta-Analytic Review of School-Based Prevention for Cannabis Use
Amy J. Porath-Waller et al.
HEALTH EDUCATION & BEHAVIOR (2010)
Pharmacotherapy for Cannabis Dependence How Close Are We?
Ryan Vandrey et al.
CNS DRUGS (2009)
Transitions from first substance use to substance use disorders in adolescence: Is early onset associated with a rapid escalation?
S. Behrendt et al.
DRUG AND ALCOHOL DEPENDENCE (2009)
Learning and memory in the aetiopathogenesis of addiction: future implications for therapy?
Christoph von der Goltz et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2009)
Cognitive-Behavioral Treatment With Adult Alcohol and Illicit Drug Users: A Meta-Analysis of Randomized Controlled Trials
Molly Magill et al.
JOURNAL OF STUDIES ON ALCOHOL AND DRUGS (2009)
The adverse health effects of cannabis use: What are they, and what are their implications for policy?
Wayne Hall
INTERNATIONAL JOURNAL OF DRUG POLICY (2009)
A meta-analytic review of psychosocial interventions for substance use disorders
Lissa Dutra et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Effects of the National Youth Anti-Drug Media Campaign on Youths
Robert Hornik et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2008)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The developmental antecedents of illicit drug use: Evidence from a 25-year longitudinal study
David M. Fergusson et al.
DRUG AND ALCOHOL DEPENDENCE (2008)
The role of risk and protective factors in substance use across adolescence
Michael J. Cleveland et al.
JOURNAL OF ADOLESCENT HEALTH (2008)
Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography
Serge Sevy et al.
PSYCHOPHARMACOLOGY (2008)
How to screen for problematic cannabis use in population surveys - An evaluation of the Cannabis Use Disorders Identification Test (CUDIT) in a Swiss sample of adolescents and young adults
B. Annaheim et al.
EUROPEAN ADDICTION RESEARCH (2008)
Toward a global view of alcohol, tobacco, cannabis, and cocaine use: Findings from the WHO World Mental Health Surveys
Louisa Degenhardt et al.
PLOS MEDICINE (2008)
Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users
Marilyn A. Huestis et al.
PSYCHOPHARMACOLOGY (2007)
Cortico-limbic circuitry for conditioned nicotine-seeking behavior in rats involves endocannabinoid signaling
E. Kodas et al.
PSYCHOPHARMACOLOGY (2007)
Correlates of cannabis initiation in a longitudinal sample of young women: The importance of peer influences
Arpana Agrawal et al.
PREVENTIVE MEDICINE (2007)
Abstinence rates following behavioral treatments for marijuana dependence
Ronald M. Kadden et al.
ADDICTIVE BEHAVIORS (2007)
Does single parenthood increase the probability of teenage promiscuity, substance use, and crime?
Heather Antecol et al.
JOURNAL OF POPULATION ECONOMICS (2007)
The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence
Kathleen M. Carroll et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2006)
The Marijuana Screening Inventory (MSI-X): Concurrent, convergent and discriminant validity with multiple measures
Dale Alexander et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2006)
The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: Reliability, validity and diagnostic cut-off
Greg Martin et al.
DRUG AND ALCOHOL DEPENDENCE (2006)
Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis
DM Fergusson et al.
ADDICTION (2006)
Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence
Alan J. Budney et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2006)
Illicit drug use and dependence in a New Zealand birth cohort
JM Boden et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2006)
Chemical constituents of marijuana: The complex mixture of natural cannabinoids
MA ElSohly et al.
LIFE SCIENCES (2005)
The Cannabis Problems Questionnaire: Factor structure, reliability, and validity
J Copeland et al.
DRUG AND ALCOHOL DEPENDENCE (2005)
The neural basis of addiction: A pathology of motivation and choice
PW Kalivas et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
The hippocampal-VTA loop: Controlling the entry of information into long-term memory
JE Lisman et al.
NEURON (2005)
Endocannabinoid release from midbrain dopamine neurons: A potential substrate for cannabinoid receptor antagonist treatment of addiction
CR Lupica et al.
NEUROPHARMACOLOGY (2005)
Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans
B Le Foll et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence
B Le Foll et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs
WD Hall et al.
DRUG AND ALCOHOL REVIEW (2005)
The opioid antagonist naltrexone reduces the reinforcing effects of Δ9-tetrahydrocannabinol (THC) in squirrel monkeys
Z Justinova et al.
PSYCHOPHARMACOLOGY (2004)
Differential control over cocaine-seeking behavior by nucleus accumbens core and shell
R Ito et al.
NATURE NEUROSCIENCE (2004)
Marijuana withdrawal in humans: Effects of oral THC or divalproex
M Haney et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
T Bisogno et al.
JOURNAL OF CELL BIOLOGY (2003)
The time course and significance of cannabis withdrawal
AJ Budney et al.
JOURNAL OF ABNORMAL PSYCHOLOGY (2003)
Adolescent precursors of cannabis dependence: findings from the Victorian Adolescent Health Cohort Study
C Coffey et al.
BRITISH JOURNAL OF PSYCHIATRY (2003)
Escalation of drug use in early-onset cannabis users vs co-twin controls
MT Lynskey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
The Marijuana Treatment Project: rationale, design and participant characteristics
RS Stephens et al.
ADDICTION (2002)
Respiratory and immunologic consequences of marijuana smoking
DP Tashkin et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Does marijuana use have residual adverse effects on self-reported health measures, socio-demographics and quality of life? A monozygotic co-twin control study in men
SA Eisen et al.
ADDICTION (2002)
Brain monoglyceride lipase participating in endocannabinoid inactivation
TP Dinh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Into the world of illegal drug use: Exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine
FA Wagner et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Blockade of effects of smoked marijuana by the CBl-selective cannabinoid receptor antagonist SR141716
MA Huestis et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Comparison of extended versus brief treatments for marijuana use
RS Stephens et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2000)
Alcohol- and drug-use disorders in australia: implications of the national survey of mental health and wellbeing
M Teesson et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2000)
Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of Δ9-tetrahydrocannabinol-tolerant rats
V Di Marzo et al.
JOURNAL OF NEUROCHEMISTRY (2000)
分享论文
